Ken Griffin Neogenomics Inc Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$13.4 - $17.73 $8,040 - $10,638	-600 Reduced 2.58%	22,700 $334,000
Q2 2024 Aug 14, 2024	SELL	$13.01 - $15.77 $689,530 - $835,810	-53,000 Reduced 69.46%	23,300 $323,000
Q1 2024 May 15, 2024	BUY	$14.06 - $16.79 $23,902 - $28,543	1,700 Added 2.28%	76,300 $1.2 Million
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $200,724 - $356,556	17,200 Added 29.97%	74,600 $1.21 Million
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $47,385 - $69,615	3,900 Added 7.29%	57,400 $706,000
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $187,530 - $263,739	13,300 Added 33.08%	53,500 $859,000
Q1 2023 May 15, 2023	SELL	$9.09 - $19.45 $41,814 - $89,470	-4,600 Reduced 10.27%	40,200 $699,000
Q4 2022 Feb 14, 2023	SELL	$6.45 - $12.07 $65,145 - $121,907	-10,100 Reduced 18.4%	44,800 $413,000
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $10,218 - $16,783	1,300 Added 2.43%	54,900 $473,000

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.89B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.